164 related articles for article (PubMed ID: 32767721)
1. Association of MAPT subhaplotypes with clinical and demographic features in Parkinson's disease.
Deutschlander AB; Konno T; Soto-Beasley AI; Walton RL; van Gerpen JA; Uitti RJ; Heckman MG; Wszolek ZK; Ross OA
Ann Clin Transl Neurol; 2020 Sep; 7(9):1557-1563. PubMed ID: 32767721
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
[TBL] [Abstract][Full Text] [Related]
3. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
[TBL] [Abstract][Full Text] [Related]
4. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
[TBL] [Abstract][Full Text] [Related]
5. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.
Valentino RR; Koga S; Walton RL; Soto-Beasley AI; Kouri N; DeTure MA; Murray ME; Johnson PW; Petersen RC; Boeve BF; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
Acta Neuropathol Commun; 2020 Dec; 8(1):218. PubMed ID: 33287913
[TBL] [Abstract][Full Text] [Related]
6. Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.
Li J; Ruskey JA; Arnulf I; Dauvilliers Y; Hu MTM; Högl B; Leblond CS; Zhou S; Ambalavanan A; Ross JP; Bourassa CV; Spiegelman D; Laurent SB; Stefani A; Charley Monaca C; Cochen De Cock V; Boivin M; Ferini-Strambi L; Plazzi G; Antelmi E; Young P; Heidbreder A; Labbe C; Ferman TJ; Dion PA; Fan D; Desautels A; Gagnon JF; Dupré N; Fon EA; Montplaisir JY; Boeve BF; Postuma RB; Rouleau GA; Ross OA; Gan-Or Z
Mov Disord; 2018 Jul; 33(6):1016-1020. PubMed ID: 29756641
[TBL] [Abstract][Full Text] [Related]
7. Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
Heckman MG; Kasanuki K; Brennan RR; Labbé C; Vargas ER; Soto AI; Murray ME; Koga S; Dickson DW; Ross OA
Mov Disord; 2019 Sep; 34(9):1325-1332. PubMed ID: 31234228
[TBL] [Abstract][Full Text] [Related]
8. Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease.
Soto-Beasley AI; Walton RL; Valentino RR; Hook PW; Labbé C; Heckman MG; Johnson PW; Goff LA; Uitti RJ; McLean PJ; Springer W; McCallion AS; Wszolek ZK; Ross OA
Parkinsonism Relat Disord; 2020 Sep; 78():138-144. PubMed ID: 32829096
[TBL] [Abstract][Full Text] [Related]
9. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.
Williams-Gray CH; Evans JR; Goris A; Foltynie T; Ban M; Robbins TW; Brayne C; Kolachana BS; Weinberger DR; Sawcer SJ; Barker RA
Brain; 2009 Nov; 132(Pt 11):2958-69. PubMed ID: 19812213
[TBL] [Abstract][Full Text] [Related]
10. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset.
Okunoye O; Ojo OO; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
Parkinsonism Relat Disord; 2023 Aug; 113():105517. PubMed ID: 37467655
[TBL] [Abstract][Full Text] [Related]
11. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
[TBL] [Abstract][Full Text] [Related]
12. Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.
Fung HC; Xiromerisiou G; Gibbs JR; Wu YR; Eerola J; Gourbali V; Hellström O; Chen CM; Duckworth J; Papadimitriou A; Tienari PJ; Hadjigeorgiou GM; Hardy J; Singleton AB
Neurodegener Dis; 2006; 3(6):327-33. PubMed ID: 17192721
[TBL] [Abstract][Full Text] [Related]
13. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
14. Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.
Winder-Rhodes SE; Hampshire A; Rowe JB; Peelle JE; Robbins TW; Owen AM; Barker RA
Neurobiol Aging; 2015 Mar; 36(3):1519-28. PubMed ID: 25577413
[TBL] [Abstract][Full Text] [Related]
15. Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.
Di Battista ME; Pascale E; Purcaro C; Passarelli F; Passarelli E; Guglielmi R; Vanacore N; Meco G
J Neural Transm (Vienna); 2014 Apr; 121(4):353-6. PubMed ID: 24253235
[TBL] [Abstract][Full Text] [Related]
16. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
[TBL] [Abstract][Full Text] [Related]
17. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
[TBL] [Abstract][Full Text] [Related]
18. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
19. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
20. A Specific Diplotype H1j/H2 of the MAPT Gene Could Be Responsible for Parkinson's Disease with Dementia.
Smaili I; Hajjaj I; Razine R; Tibar H; Salmi A; Bouslam N; Moussa A; Regragui W; Bouhouche A
Case Rep Genet; 2020; 2020():8813344. PubMed ID: 33343949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
